Imatinib mesylate may induce long-term clinical response in FIP1L1-PDGFRα-negative hypereosinophilic syndromeGrzegorz Helbig, Sławomira Kyrcz‐Krzemień, Marek Hus et al.|Medical Oncology|2011Cited by 28
Clinical characteristics of patients with chronic eosinophilic leukaemia (CEL) harbouring FIP1L1‐PDGFRA fusion transcript—results of Polish multicentre studyGrzegorz Helbig, Sławomira Kyrcz‐Krzemień, Alina Świderska et al.|Hematological Oncology|2009Cited by 23